A novel BH3-mimetic, AZD0466, targeting BCL-XL and BCL-2 is effective in pre-clinical models of malignant pleural mesothelioma

Malignant pleural mesothelioma (MPM) is an aggressive cancer with treatment limited to Cisplatin and Pemetrexed chemotherapy. Recently, we showed that drugs targeting the BCL-2-regulated apoptosis pathway could kill MPM cell lines in vitro, and control tumor growth in vivo. These studies showed BCL-...

Descripción completa

Detalles Bibliográficos
Autores principales: Arulananda, Surein, O’Brien, Megan, Evangelista, Marco, Jenkins, Laura J., Poh, Ashleigh R., Walkiewicz, Marzena, Leong, Trishe, Mariadason, John M., Cebon, Jonathan, Balachander, Srividya B., Cidado, Justin R., Lee, Erinna F., John, Thomas, Fairlie, Walter D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163735/
https://www.ncbi.nlm.nih.gov/pubmed/34050131
http://dx.doi.org/10.1038/s41420-021-00505-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163735/
https://www.ncbi.nlm.nih.gov/pubmed/34050131
http://dx.doi.org/10.1038/s41420-021-00505-0

Ejemplares similares